CJC1295 with DAC

Description

CJC1295 with DAC — GHRH Analogue with Drug Affinity Complex

CJC-1295 with DAC is a synthetic analogue of growth hormone-releasing hormone (GHRH 1-29) modified with a Drug Affinity Complex (DAC) that enables covalent binding to serum albumin. It is supplied for in vitro laboratory research only.

Research context

Preclinical literature has examined this analogue in GHRH receptor (GHRHR) binding assays and in pituitary cell culture models of secretagogue signalling. Comparative studies have characterised albumin-binding kinetics and receptor-residence time relative to unmodified GHRH fragments.

Specification

• Available sizes: 2mg · 5mg
• Form: lyophilised powder
• Purity: ≥99% (HPLC)
• Testing: independently lot-tested by Horizon Analytical · Certificate of Analysis per lot

For laboratory research use only. This material is supplied to qualified researchers and institutions for in vitro investigational use. It is not a drug, food, cosmetic or medical device. It is not intended for human or veterinary use, for diagnosis, treatment, cure or prevention of any disease, or for any use outside a controlled laboratory environment. No statement on this site has been evaluated by the Food and Drug Administration. Keep out of reach of children.

Related Research

Compound family: CJC-1295 (No DAC), CJC-1295 (No DAC) + Ipamorelin, Ipamorelin, Sermorelin

Browse: Growth Factor & Endocrine Research · All Research Peptides

Reconstitution & Lab Testing: All products independently tested by Horizon Analytical. See our Reconstitution & Lab Testing FAQ. Reconstitution typically requires BAC Water.